Trials / Unknown
UnknownNCT02966964
A Clinical Trials to Evaluate the Efficacy and Safety of Tenofovir With and Without DWPUR001 in Patients With HBV
An Exploratory, Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of Tenofovir With and Without DWPUR001 in Patients With Hepatitis B Virus(HBV)
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Uijeongbu St. Mary Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years – 69 Years
- Healthy volunteers
- Not accepted
Summary
The patient who meets the inclusion/exclusion criteria is assigned to Test1 group or Test 2 group or control group randomly. All subjects take one pill of Viread® Tab. (Tenofovir Disoproxil Fumarate 300mg) once a day for 48 weeks. At the same time, all randomized subjects take two pills of DWPUR001 or Placebo of DWPUR001 twice a day for 48 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWPUR001 | |
| DRUG | Placebo |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2018-11-01
- Completion
- 2019-02-01
- First posted
- 2016-11-17
- Last updated
- 2017-09-25
Locations
6 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02966964. Inclusion in this directory is not an endorsement.